Clinical Trial Update: A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 study of ixazomib with dexamethasone in adults with relapsed and/or refractory multiple myeloma completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• ixazomib (ixazomib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Relapsed and/or Refractory Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2021-10-27